Bitter ABS medicine for AYUSH

Manufacturers cry foul as they receive notices from state boards to pay royalty

Maths of Gilead's hepatitis C drug

Why US firm's super expensive drug sofosbuvir costs so much and how it can be made at a tenth of current price

The promise of Dayamani

Adivasi activists, however successful in mobilising grassroots struggles, have seldom been able to make a dent in Parliament. Will Dayamani Barla …

Keeping Internet global and free

With the US pulling out of the control of the Internet, the world is debating a multi-stakeholder model of governance

Why experts want GM freeze

Say regulatory system has grave deficiencies; challenge agriculture ministry’s claims

Iran-India gas pipeline laid low by geopolitics

Mani Shankar Aiyar is known for the many controversies sparked by his provocative comments and controversial ideas. As Minister for Petroleum and …

Yale guide to fighting drug patent barriers

How human rights can be used to challenge oppressive intellectual property laws

Agroecology is the only way

Rajasthan scraps seed pacts

ICAR tells Rajasthan to wait for guidelines on benefit sharing, biosafety

US plays dirty on tar sands

The EU appears to have backed off on important climate change policy because of pressure from US-backed Big Oil

G8 and tragedy of Africa

Rich nations are forcing African states to change laws to facilitate private investment in agriculture in a replay of colonial adventurism

Evergreen Novartis

The Swiss pharma giant’s challenge to India’s patent law, now in the Supreme Court, may help define drug efficacy

Annihilation of caste and copyright claims

Ambedkar’s works have been published widely and yet pose a copyright conundrum

How I stopped worrying and learned to love Fukushima

Cipla's audacious move

Why generics maker Cipla has asked government to revoke Novartis patent on respiratory ailment drug

Flame in the rainforest

LATHA JISHNU discovers how indigenous communities in Ecuador are fighting to protect Amazonia from oil extraction

Monsanto does it again

The biotech seed giant sues a farmer for planting unbranded commodity seeds bought in the open market for patent infringement

Memories of Agent Orange

Gunning for green tech

US continues to target India over its intellectual property regime, especially in pharma, green tech sectors

Debating science risks

Chinese scientists appear to be more open to discussing the risks and ethics of new technologies than their Indian counterparts

Crazy GM patent system

The Brazilian lawsuit against Monsanto’s royalty on soybean seeds exposes the irrational way in which laws apply to GM crops

Righting the copywrong

Amending the Copyright Act to give directors, composers and musicians rights over their work has corrected a historic wrong but trouble is brewing

A plant breeder comes into his own

Awards are finally coming to K Vinod Prabhu, 54, a plant breeder, for his work on building resistance in wheat, mustard and rice through the …

Who is watching GM crops?

As India gets ready to unleash a vast number of genetically modified (GM) food crops, politicians have joined activists in opposing engineered …

Getting more with less

System of crop intensification, specially in rice, has shown sizeable savings in water and seed usage. Yet its adoption has not spread despite …